Cargando…
Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders
In the present study the use of extracellular vesicles (EVs) as vehicles for therapeutic enzymes in lysosomal storage disorders was explored. EVs were isolated from mammalian cells overexpressing alpha‐galactosidase A (GLA) or N‐sulfoglucosamine sulfohydrolase (SGSH) enzymes, defective in Fabry and...
Autores principales: | Seras‐Franzoso, Joaquin, Díaz‐Riascos, Zamira V., Corchero, José Luis, González, Patricia, García‐Aranda, Natalia, Mandaña, Mònica, Riera, Roger, Boullosa, Ana, Mancilla, Sandra, Grayston, Alba, Moltó‐Abad, Marc, Garcia‐Fruitós, Elena, Mendoza, Rosa, Pintos‐Morell, Guillem, Albertazzi, Lorenzo, Rosell, Anna, Casas, Josefina, Villaverde, Antonio, Schwartz, Simó, Abasolo, Ibane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953474/ https://www.ncbi.nlm.nih.gov/pubmed/33738082 http://dx.doi.org/10.1002/jev2.12058 |
Ejemplares similares
-
The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers
por: Andrade, Fernanda, et al.
Publicado: (2023) -
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
por: Cámara-Sánchez, Patricia, et al.
Publicado: (2022) -
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
por: Pesarrodona, Mireia, et al.
Publicado: (2019) -
Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells
por: Gener, Petra, et al.
Publicado: (2019) -
Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
por: Villaverde, Antonio, et al.
Publicado: (2012)